ALI NAJI
Medical Practice in North Wales, PA
License number
Pennsylvania MD035504L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
North Wales, PA 19454
Personal information
See more information about ALI NAJI at radaris.comName
Address
Phone
141 Evergreen Ct #22, Blue Bell, PA 19422
141 Evergreen Ct, Blue Bell, PA 19422
153 Orchard Ct, Blue Bell, PA 19422
141 Evergreen Ct, Blue Bell, PA 19422
141 Evergreen Ct, Ambler, PA 19002
Professional information
Pancreatic Islet Cells Composition And Methods
US Patent:
2010027, Oct 28, 2010
Filed:
Apr 10, 2008
Appl. No.:
12/595411
Inventors:
Ali Naji - North Wales PA, US
Ming Yu - Wallingford PA, US
Chengyang Liu - Philidelphia PA, US
Omaida C. Velazquez - Miami FL, US
Ming Yu - Wallingford PA, US
Chengyang Liu - Philidelphia PA, US
Omaida C. Velazquez - Miami FL, US
International Classification:
A61K 35/39, A61P 3/10
US Classification:
424 9321, 424 937
Abstract:
A composition comprising islet cells and an extracellular matrix component as well as methods of transplanting same are described. Retroperitoneal and subcutaneous islet cells transplants maintain their viability and increased insulin production for prolonged periods of time.
Screening For Cd93 (C1Qrp)-Associated Polymorphism(S) In The Diagnosis, Prevention And Treatment Of Autoimmune Diseases
US Patent:
2011001, Jan 20, 2011
Filed:
Dec 19, 2007
Appl. No.:
12/520515
Inventors:
Hooman Noorchashm - Narberth PA, US
Ali Naji - North Wales PA, US
Ali Naji - North Wales PA, US
Assignee:
THE TRUSTEES OF THE UNIVESITY OF PENNSYLVANIA - Philidelphia PA
International Classification:
C12Q 1/68, C07H 21/04, C07H 21/00, C12N 15/63, C07K 14/705, C07K 16/28, G01N 33/566
US Classification:
435 6, 536 235, 536 231, 4353201, 530396, 5303879, 435 724
Abstract:
This invention is directed to a marker gene for autoimmune disease. Specifically, the invention is directed to the use of a polymorph of CD93 in methods and compositions for the detection, prognosis and therapy of Type I Diabetes and systemic lupus erythematosus (SLE).
Methods For Reducing The Level Of Alloantibodies In A Subject
US Patent:
2013002, Jan 31, 2013
Filed:
Apr 27, 2010
Appl. No.:
13/266446
Inventors:
Ali Naji - North Wales PA, US
International Classification:
A61K 39/395, A61P 37/06
US Classification:
4241351, 4241421, 4241451, 4241331
Abstract:
The invention provides a method for reducing the level of alloantibodies in a sensitized patient awaiting kidney transplantation by administering Belimumab or an antibody that specifically binds a B-lymphocyte stimulator protein (BLyS). The invention further provides a method for reducing the risk of an allograft rejection in an allograft recipient by administering Belimumab or an antibody that specifically binds a BLyS.